Skip to Content

ML P17 2 mg (Doxazosin Mesylate 2 mg)

Pill with imprint ML P17 2 mg is Yellow, Elliptical / Oval and has been identified as Doxazosin Mesylate 2 mg. It is supplied by Dava Pharmaceuticals Inc..

Doxazosin is used in the treatment of benign prostatic hyperplasia; raynaud's syndrome; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ML P17 2 mg

Doxazosin mesylate 2 mg ML P17 2 mg
Doxazosin mesylate 2 mg ML P17 2 mg
Doxazosin mesylate 2 mg ML P17 2 mg

Doxazosin Mesylate

Imprint
ML P17 2 mg
Strength
2 mg
Color
Yellow
Size
10.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dava Pharmaceuticals Inc.
National Drug Code (NDC)
67253-0381
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type B potato, magnesium stearate, sodium lauryl sulfate, D&C Yellow No. 10, FD&C Yellow No. 6, aluminum oxide, lactose

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.